Aarti Drugs Limited has announced its audited financial results for the quarter and half-year ended September 30, 2026. The company reported a consolidated net profit attributable to owners of ₹8,294 lakhs, marking a significant increase compared to the previous year. Revenue from operations also showed positive growth across both standalone and consolidated figures for the quarter and year-to-date periods.
Aarti Drugs Announces Strong Q2 Performance
Aarti Drugs Limited has released its audited financial results for the second quarter and the first half of the financial year ending September 30, 2026. The company showcased robust financial performance, with consolidated net profit attributable to owners reaching ₹8,294 lakhs for the quarter. This represents a substantial increase over the corresponding period in the previous financial year.
Key Financial Highlights (Consolidated)
The consolidated statement of financial results indicates a healthy upward trend. For the quarter ended September 30, 2026, the profit attributable to owners stood at ₹8,294 lakhs, compared to ₹4,528 lakhs in the same quarter of the prior year. Total comprehensive income attributable to owners also saw an increase, reaching ₹8,248 lakhs for the quarter.
Revenue from operations for the consolidated entity was reported at ₹82,624 lakhs for the quarter ended September 30, 2026, a notable rise from ₹65,279 lakhs recorded in the corresponding quarter of the previous year. The year-to-date figures also reflect positive momentum.
Standalone Performance
On a standalone basis, Aarti Drugs Limited reported a profit for the quarter ended September 30, 2026, amounting to ₹5,768 lakhs. This demonstrates consistent performance across both its consolidated and standalone operations.
Auditor’s Report and Declaration
The financial results have been audited by Gokhale & Sathe LLP, Chartered Accountants, who have provided an unmodified audit opinion for both standalone and consolidated financials. The company has confirmed that the results comply with the applicable accounting standards and regulations.
Source: BSE
